MAI Capital Management bought a new position in shares of Stericycle Inc (NASDAQ:SRCL) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,758 shares of the business services provider’s stock, valued at approximately $245,000.
A number of other institutional investors have also bought and sold shares of the business. Mackay Shields LLC acquired a new stake in shares of Stericycle in the first quarter valued at about $841,000. Robeco Institutional Asset Management B.V. grew its position in shares of Stericycle by 54.3% in the first quarter. Robeco Institutional Asset Management B.V. now owns 6,478 shares of the business services provider’s stock valued at $380,000 after purchasing an additional 2,281 shares during the last quarter. Schwab Charles Investment Management Inc. grew its position in shares of Stericycle by 9.4% in the first quarter. Schwab Charles Investment Management Inc. now owns 553,489 shares of the business services provider’s stock valued at $32,396,000 after purchasing an additional 47,593 shares during the last quarter. Neuberger Berman Group LLC grew its position in Stericycle by 2,542.8% during the first quarter. Neuberger Berman Group LLC now owns 483,580 shares of the business services provider’s stock worth $28,304,000 after buying an additional 465,282 shares in the last quarter. Finally, Korea Investment CORP acquired a new stake in Stericycle during the first quarter worth about $2,193,000. 95.47% of the stock is currently owned by hedge funds and other institutional investors.
In other Stericycle news, CFO Daniel Ginnetti sold 5,000 shares of Stericycle stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $70.00, for a total transaction of $350,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold a total of 10,060 shares of company stock valued at $707,912 in the last ninety days. Company insiders own 3.50% of the company’s stock.
A number of equities research analysts recently weighed in on SRCL shares. BidaskClub downgraded Stericycle from a “buy” rating to a “hold” rating in a research report on Saturday, September 22nd. BMO Capital Markets cut their price target on shares of Stericycle from $71.00 to $63.00 and set a “market perform” rating for the company in a research note on Monday, August 6th. Zacks Investment Research upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research note on Monday, October 1st. Robert W. Baird restated a “hold” rating and set a $70.00 price target on shares of Stericycle in a research note on Friday, August 3rd. Finally, Barrington Research set a $72.00 price target on shares of Stericycle and gave the stock a “buy” rating in a research note on Friday, October 5th. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $71.29.
SRCL stock traded down $0.44 during trading on Friday, hitting $52.55. The company had a trading volume of 996,613 shares, compared to its average volume of 900,560. The company has a debt-to-equity ratio of 0.87, a current ratio of 0.81 and a quick ratio of 0.81. Stericycle Inc has a 12 month low of $51.45 and a 12 month high of $76.73. The stock has a market capitalization of $5.04 billion, a PE ratio of 12.11, a price-to-earnings-growth ratio of 1.38 and a beta of 0.35.
Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, August 2nd. The business services provider reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.04. Stericycle had a net margin of 5.03% and a return on equity of 14.04%. The firm had revenue of $883.30 million during the quarter, compared to analyst estimates of $896.62 million. During the same quarter in the previous year, the business earned $1.15 EPS. The business’s quarterly revenue was down 3.7% compared to the same quarter last year. As a group, equities analysts expect that Stericycle Inc will post 4.43 earnings per share for the current fiscal year.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Further Reading: Book Value Per Share in Stock Trading
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.